Contamination by human and veterinary pharmaceutical derivatives refers to the undesirable presence of drug residues in the environment, including water, soil, and living organisms. This contamination can occur at various stages, including production, consumption, and disposal of medications. Main sources include releases from pharmaceutical facilities, wastewater discharges containing drug residues, and uncontrolled use of veterinary drugs in agriculture.
Pharmaceutical contamination raises environmental and health concerns, impacting ecosystems and posing risks of antibiotic-resistant bacteria emergence. Conventional wastewater treatment methods may not efficiently remove these compounds, contributing to their persistence. Efforts are underway to develop advanced treatment technologies and sustainable pharmaceutical waste management practices. Regulations aim to limit releases and promote environmental monitoring to assess the extent of contamination by pharmaceutical derivatives.

Pharmaceuticals

Contamination by human and veterinary pharmaceutical derivatives refers to the undesirable presence of drug residues in the environment, including water, soil, and living organisms. This contamination can occur at various stages, including production, consumption, and disposal of medications. Main sources include releases from pharmaceutical facilities, wastewater discharges containing drug residues, and uncontrolled use of veterinary drugs in agriculture. Pharmaceutical contamination raises environmental and health concerns, impacting ecosystems and posing risks of antibiotic-resistant bacteria emergence. Conventional wastewater treatment methods may not efficiently remove these compounds, contributing to their persistence. Efforts are underway to develop advanced treatment technologies and sustainable pharmaceutical waste management practices. Regulations aim to limit releases and promote environmental monitoring to assess the extent of contamination by pharmaceutical derivatives.

CILASTATIN FOR SYSTEM SUITABILITY 2 CRS (5 MG)

CILASTATIN FOR SYSTEM SUITABILITY 2 CRS (5 MG)

81129-83-1

DISCOVER
CHLORMADINONE ACETATE CRS (130 MG)

CHLORMADINONE ACETATE CRS (130 MG)

302-22-7

DISCOVER
ZIDOVUDINE IMPURITY D CRS (15MG)

ZIDOVUDINE IMPURITY D CRS (15MG)

76-84-6

DISCOVER
VALACICLOVIR IMPURITY S CRS (15 MG)

VALACICLOVIR IMPURITY S CRS (15 MG)

NA

DISCOVER
CHLORMADINONE ACETATE IMPURITY G CRS (25 MG)

CHLORMADINONE ACETATE IMPURITY G CRS (25 MG)

302-23-8

DISCOVER
QUETIAPINE FUMARATE CRS (50 MG)

QUETIAPINE FUMARATE CRS (50 MG)

111974-72-2

DISCOVER
BRIMONIDINE TARTRATE CRS (5 MG)

BRIMONIDINE TARTRATE CRS (5 MG)

70359-46-5

DISCOVER
HUMAN COAGULATION FACTOR IX (RDNA) CRS (10 MG)

HUMAN COAGULATION FACTOR IX (RDNA) CRS (10 MG)

NA

DISCOVER
ESOMEPRAZOLE MAGNESIUM DIHYDRATE CRS (15 MG)

ESOMEPRAZOLE MAGNESIUM DIHYDRATE CRS (15 MG)

217087-10-0

DISCOVER
SELAMECTIN IMPURITY B CRS (0.005 MG)

SELAMECTIN IMPURITY B CRS (0.005 MG)

NA

DISCOVER
VALACICLOVIR IMPURITY P CRS (5 MG)

VALACICLOVIR IMPURITY P CRS (5 MG)

NA

DISCOVER
HUMAN COAGULATION FACTOR VIIA(RDNA) CRS (42 MG)

HUMAN COAGULATION FACTOR VIIA(RDNA) CRS (42 MG)

NA

DISCOVER